Letter: Buprenorphine Receipt Is Uncommon in Older Adults with Cancer

Abstract

Get full access to this article

View all access options for this article.

References

Degnan

, Mousa

. A narrative review of buprenorphine in adult cancer pain. Expert Rev Clin Pharmacol, 2020; 13(10):1159–1167; doi: 10.1080/17512433.2020.1822163

Check

, Soneji

, Cohen

, et al. Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer. J Natl Cancer Inst, 2025; 117(7):1465–1473; doi: 10.1093/jnci/djaf072

Chwistek

, Sherry

, Kinczewski

, et al. Should buprenorphine be considered a first-line opioid for the treatment of moderate to severe cancer pain? J Pain Symptom Manage, 2023; 66(5):e638–e643; doi: 10.1016/j.jpainsymman.2023.06.022

Becker

, Seal

, Nelson

, et al.; VOICE Study Group. Buprenorphine, pain, and opioid use in patients taking high-dose long-term opioids: A randomized clinical trial. JAMA Intern Med, 2025; 185(4):372–381; doi: 10.1001/jamainternmed.2024.8361